Wang F, Tang J, Li Z, Qi Y, et al. Oral methotrexate at doses 15-25 mg/week is non-inferior to parenteral regarding efficacy and safety in the treatment of rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol 2022 Jun 7. pii: 10.1007/s10067-022-06221.
PMID: 35672619